• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, January 9, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Can we harness a plant’s ability to synthesize medicinal compounds?

Bioengineer by Bioengineer
November 24, 2020
in Chemistry
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Knowledge could guide development of sustainable production methods for plant-based medicines

IMAGE

Credit: From Flora De Filipinas by Francisco Manuel Blanco in U.S. public domain

Palo Alto, CA– Anthraquinones are a class of naturally occurring compounds prized for their medicinal properties, as well as for other applications, including ecologically friendly dyes. Despite wide interest, the mechanism by which plants produce them has remained shrouded in mystery until now.

New work from an international team of scientists including Carnegie’s Sue Rhee reveals a gene responsible for anthraquinone synthesis in plants. Their findings could help scientists cultivate a plant-based mechanism for harvesting these useful compounds in bulk quantities.

“Senna tora is a legume with anthraquinone-based medicinal properties that have long been recognized in ancient Chinese and Ayurvedic traditions, including antimicrobial and antiparasitic benefits, as well as diabetes and neurodegenerative disease prevention,” Rhee explained.

Despite its extensive practical applications, genomic studies of Senna have been limited. So, led by Sang-Ho Kang of the Korean National Institute of Agricultural Sciences and Ramesh Prasad Pandey of Sun Moon University and MIT, the research team used an array of sophisticated genetic and biochemical approaches to identify the first known anthranoid-forming enzyme in plants.

“Now that we’ve established the first step of the ladder, we can move quickly to elucidate the full suite of genes involved in the synthesis of anthraquinone,” said lead author Kang.

Once the process by which plants make these important compounds is fully known, this knowledge can be used to engineer a plant to produce high concentrations of anthraquinones that can be used medicinally.

“The same techniques that we use to help improve the yields of agricultural or biofuel crops can also be applied to developing sustainable production methods for plant-based medicines,” Rhee concluded.

###

The researchers’ work was published last week in Nature Communications.

This work was funded by the National Institute of Agricultural

Sciences and Cooperative Research Program for Agriculture Science and Technology Development, Rural Development Administration, Republic of Korea; the U.S. National Institutes of Health; and the U.S. National Science Foundation.

Media Contact
Sue Rhee
[email protected]

Related Journal Article

http://dx.doi.org/10.1038/s41467-020-19681-1

Tags: BiochemistryBiologyCell BiologyEcology/EnvironmentPharmaceutical ChemistryPhysiologyPlant Sciences
Share14Tweet9Share3ShareShareShare2

Related Posts

blank

Advancing Alkene Chemistry: Homologative Difunctionalization Breakthrough

January 8, 2026
Biocompatible Ligand Enables Safe In-Cell Protein Arylation

Biocompatible Ligand Enables Safe In-Cell Protein Arylation

January 8, 2026

Monovalent Pseudo-Natural Products Boost IDO1 Degradation

January 7, 2026

Catalytic Enantioselective [1,2]-Wittig Rearrangement Breakthrough

January 7, 2026
Please login to join discussion

POPULAR NEWS

  • Enhancing Spiritual Care Education in Nursing Programs

    154 shares
    Share 62 Tweet 39
  • PTSD, Depression, Anxiety in Childhood Cancer Survivors, Parents

    144 shares
    Share 58 Tweet 36
  • Impact of Vegan Diet and Resistance Exercise on Muscle Volume

    46 shares
    Share 18 Tweet 12
  • SARS-CoV-2 Subvariants Affect Outcomes in Elderly Hip Fractures

    45 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Amino Acid Metabolism: New Hope for Cholangiocarcinoma

Unraveling the Assembly and Evolution of Bacterial Motors

Hepatokine Fibrinogen-Like Protein 1 Fuels Kidney Fibrosis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 71 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.